Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761 ®

• Main Authors: Kandiah, N, Ong, P.A, Yuda, T, Ng, L.-L, Mamun, K, Merchant, R.A, Chen, C, Dominguez, J, Marasigan, S, Ampil, E, Nguyen, V.T, Yusoff, S, Chan, Y.F, Yong, F.M, Krairit, O, Suthisisang, C, Senanarong, V, Ji, Y, Thukral, R, Ihl, R
• Other Authors: MEDICINE
• Format: Article
• Published: 2020
• Subjects: cholinesterase inhibitor; Ginkgo biloba extract; memantine; n methyl dextro aspartic acid receptor blocking agent; placebo; add on therapy; Alzheimer disease; Article; Asia; behavior; bleeding; cerebrovascular disease; clinical practice; cognition; comorbidity; consensus; controlled study; daily life activity; dementia; disease association; disease severity; drug efficacy; drug response; drug safety; evidence based practice; human; mental disease; mild cognitive impairment; monotherapy; multiinfarct dementia; practice guideline; quality of life; randomized controlled trial; risk benefit analysis
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/178046
• Institution: National University of Singapore

10.1111/cns.13095